140 related articles for article (PubMed ID: 24392879)
1. Inhibition of SATB1 by shRNA suppresses the proliferation of cutaneous malignant melanoma.
Zhang L; Cheng F; He R; Chen H; Liu Y; Sun J
Cancer Biother Radiopharm; 2014 Mar; 29(2):77-82. PubMed ID: 24392879
[TBL] [Abstract][Full Text] [Related]
2. Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells.
Frömberg A; Rabe M; Oppermann H; Gaunitz F; Aigner A
BMC Cancer; 2017 Jan; 17(1):3. PubMed ID: 28049521
[TBL] [Abstract][Full Text] [Related]
3. Multiple effects of the special AT-rich binding protein 1 (SATB1) in colon carcinoma.
Frömberg A; Rabe M; Aigner A
Int J Cancer; 2014 Dec; 135(11):2537-46. PubMed ID: 24729451
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic virus carrying shRNA targeting SATB1 inhibits prostate cancer growth and metastasis.
Mao LJ; Zhang J; Liu N; Fan L; Yang DR; Xue BX; Shan YX; Zheng JN
Tumour Biol; 2015 Nov; 36(11):9073-81. PubMed ID: 26084613
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression.
Shukla S; Sharma H; Abbas A; MacLennan GT; Fu P; Danielpour D; Gupta S
PLoS One; 2013; 8(1):e53527. PubMed ID: 23308245
[TBL] [Abstract][Full Text] [Related]
6. SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC).
Panchal O; Wichmann G; Grenman R; Eckhardt L; Kunz-Schughart LA; Franke H; Dietz A; Aigner A
Sci Rep; 2020 May; 10(1):8615. PubMed ID: 32451408
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of SATB1 increases the invasiveness of Jurkat cell via activation of the WNT/β-catenin signaling pathway in vitro.
Luo XD; Yang SJ; Wang JN; Tan L; Liu D; Wang YY; Zheng RH; Wu XH; Xu LH; Tan H
Tumour Biol; 2016 Jun; 37(6):7413-9. PubMed ID: 26678884
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma.
Chen H; Takahara M; Oba J; Xie L; Chiba T; Takeuchi S; Tu Y; Nakahara T; Uchi H; Moroi Y; Furue M
J Dermatol Sci; 2011 Oct; 64(1):39-44. PubMed ID: 21767935
[TBL] [Abstract][Full Text] [Related]
9. Silencing SATB1 inhibits the malignant phenotype and increases sensitivity of human osteosarcoma U2OS cells to arsenic trioxide.
Zhang H; Su X; Guo L; Zhong L; Li W; Yue Z; Wang X; Mu Y; Li X; Li R; Wang Z
Int J Med Sci; 2014; 11(12):1262-9. PubMed ID: 25317073
[TBL] [Abstract][Full Text] [Related]
10. Fluvastatin-mediated down-regulation of SATB1 affects aggressive phenotypes of human non-small-cell lung cancer cell line H292.
Xu HY; Xue JX; Gao H; Na FF; Li H; Zhang T; Lu Y
Life Sci; 2019 Apr; 222():212-220. PubMed ID: 30557545
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human glioma U251 cells growth in vitro and in vivo by hydroxyapatite nanoparticle-assisted delivery of short hairpin RNAs against SATB1.
Chu SH; Zhou ZM; Feng DF; Ma YB
Mol Biol Rep; 2014 Feb; 41(2):977-86. PubMed ID: 24370885
[TBL] [Abstract][Full Text] [Related]
12. Functional effects of GRM1 suppression in human melanoma cells.
Wangari-Talbot J; Wall BA; Goydos JS; Chen S
Mol Cancer Res; 2012 Nov; 10(11):1440-50. PubMed ID: 22798429
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of doxorubicin and SATB1 shRNA by thermosensitive magnetic cationic liposomes for gastric cancer therapy.
Peng Z; Wang C; Fang E; Lu X; Wang G; Tong Q
PLoS One; 2014; 9(3):e92924. PubMed ID: 24675979
[TBL] [Abstract][Full Text] [Related]
14. [SATB1 promotes the malignant of human non-Hodgkin lymphoma by activating the ribonucleotide reductase
small subunit M2].
Yan D; Wang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 41(11):1155-1162. PubMed ID: 27932760
[TBL] [Abstract][Full Text] [Related]
15. Silencing SATB1 inhibits proliferation of human osteosarcoma U2OS cells.
Zhang H; Qu S; Li S; Wang Y; Li Y; Wang Y; Wang Z; Li R
Mol Cell Biochem; 2013 Jun; 378(1-2):39-45. PubMed ID: 23516037
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of long noncoding RNA UCA1 by SATB1 in breast cancer.
Lee JJ; Kim M; Kim HP
BMB Rep; 2016 Oct; 49(10):578-583. PubMed ID: 27697109
[TBL] [Abstract][Full Text] [Related]
17. SATB1 promotes prostate cancer metastasis by the regulation of epithelial-mesenchymal transition.
Mao LJ; Yang CH; Fan L; Gao P; Yang DR; Xue BX; Zheng JN; Shan YX
Biomed Pharmacother; 2016 Apr; 79():1-8. PubMed ID: 27044805
[TBL] [Abstract][Full Text] [Related]
18. SATB1 3'-UTR and lncRNA-UCA1 competitively bind to miR-495-3p and together regulate the proliferation and invasion of gastric cancer.
Sun L; Liu L; Yang J; Li H; Zhang C
J Cell Biochem; 2019 Apr; 120(4):6671-6682. PubMed ID: 30368875
[TBL] [Abstract][Full Text] [Related]
19. Satb1 Overexpression Drives Tumor-Promoting Activities in Cancer-Associated Dendritic Cells.
Tesone AJ; Rutkowski MR; Brencicova E; Svoronos N; Perales-Puchalt A; Stephen TL; Allegrezza MJ; Payne KK; Nguyen JM; Wickramasinghe J; Tchou J; Borowsky ME; Rabinovich GA; Kossenkov AV; Conejo-Garcia JR
Cell Rep; 2016 Feb; 14(7):1774-1786. PubMed ID: 26876172
[TBL] [Abstract][Full Text] [Related]
20. Silencing SATB1 influences cell invasion, migration, proliferation, and drug resistance in nasopharyngeal carcinoma.
Ye CS; Zhou DN; Yang QQ; Deng YF
Int J Clin Exp Pathol; 2014; 7(3):914-22. PubMed ID: 24696710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]